Loading...
「ツール」は右上に移動しました。
利用したサーバー: wtserver2
1いいね 20回再生

Engaging Endogenous Immunity with CAR T cells

Presented By: Sarwish Rafiq, PhD

Speaker Biography: Sarwish Rafiq, PhD is an Assistant Professor in the Department of Hematology and Medical Oncology at the Emory School of Medicine. She is a translational scientist who's research aims to use mechanistic insight of immune effector cell function against cancer cells in the tumor microenvironment to inform the development of novel and effective cellular therapies.

Webinar: Engaging Endogenous Immunity with CAR T cells

Webinar Abstract: Despite the remarkable clinical efficacy of chimeric antigen receptor (CAR) T cells in hematological malignancies, only a subset of patients achieve a durable complete response. Furthermore, significant obstacles to CAR T cell therapy remain to treat solid tumors. Complex immunosuppressive tumor microenvironments (TME) and the exploitation of checkpoint pathways allow tumors to evade the immune system. We have developed novel methods to create CAR T cells enriched with T cells of memory phenotypes that have improved metabolic fitness for both hematological and solid tumors.

Earn PACE Credits:
1. Make sure you’re a registered member of Labroots (www.labroots.com/)
2. Watch the webinar on YouTube or on the Labroots Website (www.labroots.com/ms/webinar/engaging-endogenous-im…)
3. Click Here to get your PACE credits (Expiration date – April 30, 2027): (www.labroots.com/credit/pace-credits/9426/cert) 

Labroots on Social:
Facebook: www.facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: www.linkedin.com/company/labroots
Instagram: www.instagram.com/labrootsinc
Pinterest: www.pinterest.com/labroots/
SnapChat: labroots_inc

コメント